Free Trial

Itron (ITRI) Financials

Itron logo
$113.28 -2.22 (-1.92%)
Closing price 04:00 PM Eastern
Extended Trading
$114.92 +1.64 (+1.44%)
As of 05:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Itron

Annual Income Statements for Itron

This table shows Itron's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
239 97 -9.73 -81 -58 49 -99 57 32 13
Consolidated Net Income / (Loss)
241 98 -9.55 -78 -57 52 -97 60 35 15
Net Income / (Loss) Continuing Operations
241 98 -9.55 -78 -57 52 -97 60 35 15
Total Pre-Tax Income
285 127 -16 -124 -57 73 -109 135 85 37
Total Operating Income
264 129 -7.44 -79 -10 133 -50 155 101 53
Total Gross Profit
839 714 522 573 602 752 730 677 663 557
Total Revenue
2,441 2,174 1,796 1,982 2,173 2,502 2,376 2,018 2,013 1,884
Operating Revenue
2,441 2,174 1,796 1,982 2,173 2,502 2,376 2,018 2,013 1,884
Total Cost of Revenue
1,602 1,460 1,273 1,408 1,571 1,750 1,646 1,341 1,351 1,327
Operating Cost of Revenue
1,602 1,460 1,273 1,408 1,571 1,750 1,646 1,341 1,351 1,327
Total Operating Expenses
575 585 530 652 613 620 780 522 562 504
Selling, General & Admin Expense
339 313 290 301 277 347 423 325 320 156
Research & Development Expense
215 209 185 197 194 202 208 169 168 162
Amortization Expense
18 19 26 36 45 64 72 21 25 32
Impairment Charge
0.00 0.00 38 0.00 0.00 - - - - -
Restructuring Charge
2.68 44 -14 55 37 6.28 77 6.42 49 -7.26
Other Special Charges / (Income)
0.60 0.67 3.51 64 60 0.00 0.00 - - -
Total Other Income / (Expense), net
20 -1.48 -8.30 -45 -46 -60 -59 -20 -16 -16
Interest Expense
15 8.35 6.72 29 44 52 58 14 14 12
Interest & Investment Income
35 9.31 2.63 1.56 3.00 1.85 2.15 2.13 0.87 0.76
Other Income / (Expense), net
1.22 -2.45 -4.21 -17 -5.24 -9.05 -3.41 -8.58 -3.71 -4.22
Income Tax Expense
43 29 -6.20 -46 0.24 21 -13 74 50 22
Net Income / (Loss) Attributable to Noncontrolling Interest
2.02 1.40 0.19 2.96 1.08 3.41 2.67 2.95 3.28 2.33
Basic Earnings per Share
$5.27 $2.13 ($0.22) ($1.83) ($1.44) $1.24 ($2.53) $1.48 $0.83 $0.33
Weighted Average Basic Shares Outstanding
45.37M 45.42M 45.10M 44.30M 40.25M 39.56M 39.24M 38.66M 38.21M 38.22M
Diluted Earnings per Share
$5.18 $2.11 ($0.22) ($1.83) ($1.44) $1.23 ($2.53) $1.45 $0.82 $0.33
Weighted Average Diluted Shares Outstanding
46.19M 45.84M 45.10M 44.30M 40.25M 39.98M 39.24M 39.39M 38.64M 38.51M
Weighted Average Basic & Diluted Shares Outstanding
45.18M 45.58M 45.29M 45.01M 40.46M 39.96M 39.20M 38.70M 38.30M -27M

Quarterly Income Statements for Itron

This table shows Itron's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
65 58 78 51 52 44 40 24 -12 22 4.12
Consolidated Net Income / (Loss)
65 59 79 52 52 45 40 25 -12 22 4.47
Net Income / (Loss) Continuing Operations
65 59 79 52 52 45 40 25 -12 22 4.47
Total Pre-Tax Income
82 70 82 67 65 49 56 34 -12 11 4.95
Total Operating Income
76 63 74 65 63 49 55 35 -10 12 6.89
Total Gross Profit
217 214 210 210 205 196 187 174 156 141 120
Total Revenue
607 613 615 609 603 577 561 541 495 467 421
Operating Revenue
607 613 615 609 603 577 561 541 495 467 421
Total Cost of Revenue
390 399 406 399 398 381 374 367 338 327 301
Operating Cost of Revenue
390 399 406 399 398 381 374 367 338 327 301
Total Operating Expenses
141 151 136 146 143 147 132 139 167 128 113
Selling, General & Admin Expense
87 85 80 88 86 82 77 79 76 78 63
Research & Development Expense
50 58 51 53 52 54 52 54 50 47 44
Amortization Expense
4.48 4.52 4.81 4.51 3.99 4.49 4.66 4.72 5.05 6.27 6.41
Restructuring Charge
-0.55 3.30 -0.72 -0.10 0.20 7.12 -0.62 0.87 37 -2.53 -1.27
Other Special Charges / (Income)
0.08 -0.06 0.70 -0.07 0.02 -0.01 0.05 0.61 0.02 0.32 0.77
Total Other Income / (Expense), net
6.07 7.12 8.49 2.39 2.42 0.19 0.84 -0.80 -1.71 -1.60 -1.94
Interest Expense
5.59 5.59 5.61 2.29 1.89 1.87 2.45 1.98 2.06 1.79 1.68
Interest & Investment Income
12 12 13 5.13 3.85 3.35 2.64 1.51 1.82 1.27 0.80
Other Income / (Expense), net
-0.05 0.53 0.68 -0.45 0.46 -1.28 0.65 -0.33 -1.48 -1.07 -1.07
Income Tax Expense
17 11 3.52 15 13 4.56 15 9.20 -0.07 -11 0.47
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.12 0.46 0.95 0.54 0.07 0.52 0.17 0.90 -0.20 -0.26 0.36
Basic Earnings per Share
$1.44 $1.29 $1.73 $1.12 $1.13 $0.98 $0.88 $0.53 ($0.26) $0.49 $0.09
Weighted Average Basic Shares Outstanding
45.34M 45.37M 44.98M 45.75M 45.65M 45.42M 45.46M 45.44M 45.28M 45.10M 45.14M
Diluted Earnings per Share
$1.42 $1.26 $1.70 $1.10 $1.12 $0.97 $0.87 $0.53 ($0.26) $0.49 $0.09
Weighted Average Diluted Shares Outstanding
46.17M 46.19M 45.84M 46.53M 46.36M 45.84M 45.95M 45.78M 45.28M 45.10M 45.33M
Weighted Average Basic & Diluted Shares Outstanding
45.59M 45.18M 45.09M 44.96M 45.87M 45.58M 45.49M 45.46M 45.42M 45.29M 45.18M

Annual Cash Flow Statements for Itron

This table details how cash moves in and out of Itron's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
749 100 39 -33 57 28 -357 345 2.55 19
Net Cash From Operating Activities
238 125 25 155 110 173 110 191 116 73
Net Cash From Continuing Operating Activities
238 125 25 155 110 173 110 191 116 73
Net Income / (Loss) Continuing Operations
241 98 -9.55 -78 -57 52 -97 60 35 15
Consolidated Net Income / (Loss)
241 98 -9.55 -78 -57 52 -97 60 35 15
Depreciation Expense
56 56 67 84 97 114 122 63 68 76
Amortization Expense
5.49 3.66 3.50 18 4.13 5.63 7.05 1.07 1.08 2.13
Non-Cash Adjustments To Reconcile Net Income
64 42 86 119 106 33 54 12 30 37
Changes in Operating Assets and Liabilities, net
-129 -75 -122 12 -41 -33 22 55 -18 -57
Net Cash From Investing Activities
-63 -23 41 -35 -41 -48 -863 -148 -48 -49
Net Cash From Continuing Investing Activities
-63 -23 41 -35 -41 -48 -863 -148 -48 -49
Purchase of Property, Plant & Equipment
-31 -27 -20 -35 -46 -61 -60 -49 -44 -44
Acquisitions
-34 0.00 0.02 -8.67 0.00 0.00 -803 -99 -0.95 -5.75
Divestitures
0.41 -0.77 56 3.14 1.13 0.00 - - - -
Other Investing Activities, net
0.85 4.35 4.31 5.33 4.04 13 0.37 0.70 -3.03 0.72
Net Cash From Financing Activities
580 -3.51 -19 -153 -12 -98 396 302 -63 7.74
Net Cash From Continuing Financing Activities
580 -3.51 -19 -153 -12 -98 396 302 -63 7.74
Repayment of Debt
-25 -7.18 -5.22 -961 -420 -147 -392 -37 -82 -70
Repurchase of Common Equity
-100 0.00 -17 -8.03 0.00 -25 0.00 0.00 - -38
Issuance of Debt
805 0.00 0.00 460 400 50 779 335 16 113
Issuance of Common Equity
8.32 3.67 3.45 440 8.89 24 9.17 3.61 2.89 2.66
Other Financing Activities, net
-109 0.00 0.00 -84 0.00 0.00 - - - -
Effect of Exchange Rate Changes
-5.15 1.89 -6.85 - 0.13 0.44 - - -2.74 -13
Cash Interest Paid
1.34 1.83 1.62 8.98 47 45 42 10 9.92 10
Cash Income Taxes Paid
80 55 12 7.07 2.69 12 14 29 24 29

Quarterly Cash Flow Statements for Itron

This table details how cash moves in and out of Itron's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
72 69 62 620 -1.44 47 22 37 -5.99 -13 6.91
Net Cash From Operating Activities
72 80 65 52 41 48 34 42 1.43 -13 15
Net Cash From Continuing Operating Activities
72 80 65 52 41 48 34 42 1.43 -13 15
Net Income / (Loss) Continuing Operations
65 59 79 52 52 45 40 25 -12 22 4.47
Consolidated Net Income / (Loss)
65 59 79 52 52 45 40 25 -12 22 4.47
Depreciation Expense
12 15 15 14 13 14 14 14 14 16 17
Amortization Expense
1.78 1.82 1.80 0.98 0.89 0.90 0.94 0.93 0.89 0.89 0.89
Non-Cash Adjustments To Reconcile Net Income
19 21 13 13 16 10 9.07 12 11 18 9.03
Changes in Operating Assets and Liabilities, net
-27 -17 -43 -28 -40 -22 -30 -10 -13 -70 -17
Net Cash From Investing Activities
-4.63 -9.03 -6.57 -6.67 -41 -4.31 -5.78 -5.56 -7.66 -2.98 -3.52
Net Cash From Continuing Investing Activities
-4.63 -9.03 -6.57 -6.67 -41 -4.31 -5.78 -5.56 -7.66 -2.98 -3.52
Purchase of Property, Plant & Equipment
-4.64 -9.68 -6.62 -7.11 -7.15 -8.58 -5.81 -5.60 -6.90 -4.86 -4.22
Acquisitions
0.00 0.02 - - -34 - - - 0.00 - -
Other Investing Activities, net
0.01 0.64 0.06 0.03 0.13 4.28 0.02 0.03 0.02 1.88 0.70
Net Cash From Financing Activities
1.76 3.49 -0.75 576 1.08 -0.87 -3.41 0.87 -0.10 0.66 0.68
Net Cash From Continuing Financing Activities
1.76 3.49 -0.75 576 1.08 -0.87 -3.41 0.87 -0.10 0.66 0.68
Repayment of Debt
-0.43 -0.52 -2.10 -22 -0.49 -2.18 -4.13 -0.17 -0.70 -0.16 -0.15
Issuance of Common Equity
2.20 4.00 1.35 1.41 1.56 1.31 0.73 1.03 0.61 0.82 0.83
Effect of Exchange Rate Changes
2.79 -5.58 3.89 -0.77 -2.68 4.56 -2.91 -0.09 0.33 1.94 -5.12
Cash Interest Paid
6.61 -2.72 3.10 0.64 0.32 0.25 0.79 0.33 0.46 0.21 0.69
Cash Income Taxes Paid
35 21 19 26 14 26 8.38 19 1.43 1.96 2.89

Annual Balance Sheets for Itron

This table presents Itron's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
3,408 2,604 2,378 2,394 2,607 2,708 2,609 2,106 1,578 1,680
Total Current Assets
1,816 1,049 830 750 930 997 896 850 732 759
Cash & Equivalents
1,051 302 202 163 207 150 120 176 134 131
Accounts Receivable
350 304 280 298 370 473 437 398 352 331
Inventories, net
271 284 229 166 182 228 221 194 163 190
Other Current Assets
143 160 118 123 171 147 118 82 84 107
Plant, Property, & Equipment, net
115 129 140 163 208 233 227 201 176 190
Total Noncurrent Assets
1,476 1,426 1,408 1,481 1,469 1,477 1,486 1,056 669 731
Goodwill
1,052 1,053 1,039 1,099 1,132 1,104 1,117 556 452 468
Intangible Assets
43 46 65 93 133 185 258 95 72 102
Noncurrent Deferred & Refundable Income Taxes
310 247 212 181 76 64 65 50 94 109
Other Noncurrent Operating Assets
71 80 93 108 128 124 47 355 50 52
Total Liabilities & Shareholders' Equity
3,408 2,604 2,378 2,394 2,607 2,708 2,609 2,106 1,578 1,680
Total Liabilities
1,996 1,273 1,187 1,251 1,767 1,907 1,875 1,301 927 1,058
Total Current Liabilities
528 537 499 501 550 671 653 508 413 478
Accounts Payable
145 200 237 193 216 328 310 262 173 186
Accrued Expenses
14 15 18 18 28 39 47 21 25 37
Current Deferred Revenue
151 124 96 83 113 100 94 41 65 73
Current Deferred & Payable Income Tax Liabilities
20 8.64 15 12 16 22 15 16 10 15
Current Employee Benefit Liabilities
137 136 89 114 86 119 89 91 82 77
Other Current Liabilities
61 54 43 81 73 64 70 57 44 79
Total Noncurrent Liabilities
1,468 736 688 750 1,217 1,236 1,222 793 514 580
Long-Term Debt
1,242 455 453 450 903 932 988 594 290 359
Noncurrent Deferred & Payable Income Tax Liabilities
0.57 0.70 0.83 2.00 1.92 1.81 1.54 1.53 3.07 1.72
Noncurrent Employee Benefit Liabilities
60 64 58 88 119 99 92 96 84 86
Other Noncurrent Operating Liabilities
165 184 132 210 126 134 141 102 136 133
Total Equity & Noncontrolling Interests
1,411 1,331 1,192 1,143 840 801 734 806 650 623
Total Preferred & Common Equity
1,391 1,311 1,168 1,116 817 777 713 786 632 605
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,391 1,311 1,168 1,116 817 777 713 786 632 605
Common Stock
1,690 1,821 1,788 1,780 1,389 1,358 1,334 1,295 1,270 1,247
Retained Earnings
-189 - - -516 - - - - - -
Accumulated Other Comprehensive Income / (Loss)
-110 -510 -620 -148 -573 -581 -622 -508 -639 -642
Noncontrolling Interest
21 21 23 27 24 24 21 19 19 18

Quarterly Balance Sheets for Itron

This table presents Itron's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
3,503 3,365 3,284 2,677 2,511 2,499 2,446 2,317
Total Current Assets
1,903 1,755 1,689 1,097 1,010 970 902 809
Cash & Equivalents
1,123 983 921 301 255 233 196 215
Accounts Receivable
347 339 317 340 318 319 305 267
Inventories, net
282 277 292 287 276 267 265 204
Other Current Assets
151 157 160 169 161 151 136 123
Plant, Property, & Equipment, net
112 120 122 125 130 133 136 139
Total Noncurrent Assets
1,488 1,490 1,472 1,454 1,372 1,396 1,407 1,369
Goodwill
1,063 1,074 1,060 1,064 1,036 1,047 1,045 1,011
Intangible Assets
39 48 53 57 50 55 60 70
Noncurrent Deferred & Refundable Income Taxes
315 290 284 250 209 214 216 189
Other Noncurrent Operating Assets
72 78 76 83 77 80 87 99
Total Liabilities & Shareholders' Equity
3,503 3,365 3,284 2,677 2,511 2,499 2,446 2,317
Total Liabilities
1,994 1,997 2,023 1,291 1,254 1,270 1,252 1,200
Total Current Liabilities
983 521 535 578 556 560 537 502
Short-Term Debt
458 - - - - - - -
Accounts Payable
164 153 185 224 224 235 245 236
Accrued Expenses
15 14 15 16 16 18 18 18
Current Deferred Revenue
188 161 160 157 137 140 131 111
Current Deferred & Payable Income Tax Liabilities
18 14 13 28 17 14 21 14
Current Employee Benefit Liabilities
90 119 106 94 107 100 77 78
Other Current Liabilities
50 61 57 60 55 53 44 47
Total Noncurrent Liabilities
1,011 1,475 1,488 713 698 710 715 697
Long-Term Debt
786 1,241 1,240 455 454 454 453 452
Noncurrent Deferred & Payable Income Tax Liabilities
0.62 0.62 0.67 0.68 0.82 0.85 0.85 1.72
Noncurrent Employee Benefit Liabilities
61 65 62 63 58 60 59 71
Other Noncurrent Operating Liabilities
163 169 186 194 152 196 202 126
Total Equity & Noncontrolling Interests
1,509 1,369 1,261 1,385 1,258 1,229 1,194 1,117
Total Preferred & Common Equity
1,488 1,348 1,240 1,365 1,238 1,205 1,171 1,094
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,488 1,348 1,240 1,365 1,238 1,205 1,171 1,094
Common Stock
1,709 1,674 1,663 1,834 1,811 1,804 1,796 1,783
Retained Earnings
-124 -247 -325 -377 - -513 -537 -
Accumulated Other Comprehensive Income / (Loss)
-96 -78 -98 -92 -574 -86 -88 -689
Noncontrolling Interest
21 20 21 21 20 24 23 23

Annual Metrics And Ratios for Itron

This table displays calculated financial ratios and metrics derived from Itron's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
12.29% 21.06% -9.39% -8.82% -13.15% 5.32% 17.73% 0.25% 6.88% -3.29%
EBITDA Growth
76.00% 217.09% 932.41% -93.38% -64.79% 218.76% -63.70% 26.34% 31.50% 36.89%
EBIT Growth
109.88% 1,184.97% 87.95% -518.63% -112.65% 332.83% -136.30% 50.38% 100.05% 779.47%
NOPAT Growth
125.03% 2,010.03% 90.62% -662.86% -107.64% 373.76% -150.17% 65.75% 95.76% 6,259.95%
Net Income Growth
145.25% 1,129.83% 87.81% -37.66% -208.51% 154.27% -260.30% 71.88% 133.64% 167.28%
EPS Growth
145.50% 1,059.09% 87.98% -27.08% -217.07% 148.62% -274.48% 76.83% 148.48% 155.00%
Operating Cash Flow Growth
90.58% 410.09% -84.17% 41.35% -36.64% 57.48% -42.64% 65.19% 57.93% -44.84%
Free Cash Flow Firm Growth
99.98% 212.73% -145.31% 464.75% -67.37% 117.36% -20.07% -527.30% 18.25% -67.92%
Invested Capital Growth
5.65% 2.05% 3.92% -11.76% -1.89% 1.34% 31.21% 51.30% -4.70% -5.31%
Revenue Q/Q Growth
1.48% 5.31% -1.00% -1.96% -4.53% 1.68% 1.55% 2.80% -0.04% 0.50%
EBITDA Q/Q Growth
5.73% 22.63% 202.50% -96.21% -0.09% -0.84% -7.33% 7.74% 10.82% 103.85%
EBIT Q/Q Growth
6.11% 40.87% 91.12% -328.88% 22.33% -1.14% -59.74% 11.14% 22.29% 329.67%
NOPAT Q/Q Growth
3.69% 27.28% 94.16% -496.72% 26.45% -16.88% -65.57% -18.37% 10.91% 291.09%
Net Income Q/Q Growth
6.01% 30.46% 89.38% -4,900.61% 11.29% -17.16% 19.07% -14.59% 9.96% 134.04%
EPS Q/Q Growth
5.93% 29.45% 89.37% -2,714.29% 10.56% -18.00% 19.17% -15.20% 9.33% 128.21%
Operating Cash Flow Q/Q Growth
15.50% 95.13% -52.13% -14.05% -5.03% 1.39% -23.91% 28.89% -14.24% 100.47%
Free Cash Flow Firm Q/Q Growth
74.89% 714.55% -109.79% -19.55% -26.22% -18.90% 37.75% -853.36% 7.00% -32.29%
Invested Capital Q/Q Growth
-1.51% 1.79% 6.11% -2.08% 0.39% -0.29% -0.16% 27.43% -3.75% -3.44%
Profitability Metrics
- - - - - - - - - -
Gross Margin
34.39% 32.84% 29.08% 28.93% 27.71% 30.06% 30.74% 33.53% 32.91% 29.56%
EBITDA Margin
13.40% 8.55% 3.26% 0.29% 3.95% 9.74% 3.22% 10.43% 8.28% 6.73%
Operating Margin
10.82% 5.93% -0.41% -4.00% -0.48% 5.30% -2.09% 7.67% 5.02% 2.81%
EBIT Margin
10.87% 5.82% -0.65% -4.88% -0.72% 4.94% -2.23% 7.25% 4.83% 2.58%
Profit (Net Income) Margin
9.88% 4.52% -0.53% -3.95% -2.62% 2.09% -4.06% 2.99% 1.74% 0.80%
Tax Burden Percent
84.74% 77.18% 60.64% 63.24% 100.42% 71.77% 88.48% 44.77% 41.42% 40.44%
Interest Burden Percent
107.24% 100.76% 135.11% 128.00% 362.23% 59.07% 205.55% 91.99% 86.99% 76.29%
Effective Tax Rate
15.26% 22.82% 0.00% 0.00% 0.00% 28.23% 0.00% 55.23% 58.58% 59.56%
Return on Invested Capital (ROIC)
14.35% 6.62% -0.36% -3.64% -0.44% 5.80% -2.42% 6.72% 4.97% 2.41%
ROIC Less NNEP Spread (ROIC-NNEP)
23.54% 6.15% -1.85% -7.90% -6.52% 0.90% -11.69% 3.73% 1.66% -0.41%
Return on Net Nonoperating Assets (RNNOA)
3.23% 1.17% -0.46% -4.26% -6.49% 1.03% -10.12% 1.56% 0.54% -0.14%
Return on Equity (ROE)
17.58% 7.79% -0.82% -7.90% -6.93% 6.83% -12.55% 8.28% 5.51% 2.27%
Cash Return on Invested Capital (CROIC)
8.85% 4.60% -4.20% 8.86% 1.46% 4.47% -29.42% -34.11% 9.79% 7.86%
Operating Return on Assets (OROA)
8.83% 5.07% -0.49% -3.87% -0.59% 4.65% -2.25% 7.94% 5.97% 2.83%
Return on Assets (ROA)
8.02% 3.95% -0.40% -3.13% -2.14% 1.97% -4.10% 3.27% 2.15% 0.87%
Return on Common Equity (ROCE)
17.32% 7.66% -0.80% -7.70% -6.73% 6.63% -12.21% 8.06% 5.35% 2.21%
Return on Equity Simple (ROE_SIMPLE)
17.34% 7.50% -0.82% -7.02% -6.97% 6.75% -13.55% 7.66% 5.55% 2.48%
Net Operating Profit after Tax (NOPAT)
224 99 -5.21 -56 -7.28 95 -35 69 42 21
NOPAT Margin
9.17% 4.58% -0.29% -2.80% -0.33% 3.81% -1.46% 3.44% 2.08% 1.13%
Net Nonoperating Expense Percent (NNEP)
-9.19% 0.48% 1.49% 4.27% 6.08% 4.90% 9.27% 2.99% 3.31% 2.82%
Return On Investment Capital (ROIC_SIMPLE)
8.43% 5.47% -0.31% - - - - - - -
Cost of Revenue to Revenue
65.61% 67.16% 70.92% 71.08% 72.29% 69.94% 69.26% 66.47% 67.09% 70.44%
SG&A Expenses to Revenue
13.89% 14.39% 16.18% 15.17% 12.74% 13.86% 17.81% 16.12% 15.87% 8.27%
R&D to Revenue
8.81% 9.60% 10.31% 9.95% 8.93% 8.08% 8.75% 8.39% 8.33% 8.62%
Operating Expenses to Revenue
23.57% 26.92% 29.50% 32.93% 28.19% 24.76% 32.83% 25.86% 27.89% 26.75%
Earnings before Interest and Taxes (EBIT)
265 126 -12 -97 -16 124 -53 146 97 49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
327 186 59 5.68 86 244 76 211 167 127
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.52 2.62 1.96 2.78 4.74 4.28 2.62 3.36 3.81 2.27
Price to Tangible Book Value (P/TBV)
16.58 16.19 35.31 0.00 0.00 0.00 0.00 19.50 22.48 39.51
Price to Revenue (P/Rev)
2.01 1.58 1.27 1.57 1.78 1.33 0.78 1.31 1.19 0.73
Price to Earnings (P/E)
20.48 35.44 0.00 0.00 0.00 67.78 0.00 46.09 75.69 108.15
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.88% 2.82% 0.00% 0.00% 0.00% 1.48% 0.00% 2.17% 1.32% 0.92%
Enterprise Value to Invested Capital (EV/IC)
3.19 2.40 1.75 2.39 2.89 2.54 1.71 2.49 3.16 1.89
Enterprise Value to Revenue (EV/Rev)
2.09 1.68 1.45 1.72 2.15 1.68 1.17 1.53 1.29 0.86
Enterprise Value to EBITDA (EV/EBITDA)
15.62 19.59 44.47 601.79 54.54 17.23 36.39 14.71 15.56 12.85
Enterprise Value to EBIT (EV/EBIT)
19.25 28.80 0.00 0.00 0.00 33.95 0.00 21.17 26.67 33.48
Enterprise Value to NOPAT (EV/NOPAT)
22.82 36.61 0.00 0.00 0.00 44.08 0.00 44.67 62.02 76.19
Enterprise Value to Operating Cash Flow (EV/OCF)
21.45 29.14 106.38 22.07 42.72 24.29 25.35 16.19 22.39 22.20
Enterprise Value to Free Cash Flow (EV/FCFF)
37.00 52.74 0.00 25.27 195.46 57.21 0.00 0.00 31.49 23.37
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.88 0.37 0.42 0.39 1.18 1.25 1.39 0.76 0.47 0.59
Long-Term Debt to Equity
0.88 0.37 0.42 0.39 1.15 1.25 1.35 0.74 0.45 0.58
Financial Leverage
0.14 0.19 0.25 0.54 0.99 1.14 0.87 0.42 0.32 0.34
Leverage Ratio
2.19 1.97 2.04 2.52 3.24 3.46 3.06 2.53 2.56 2.60
Compound Leverage Factor
2.35 1.99 2.76 3.23 11.73 2.05 6.29 2.33 2.23 1.98
Debt to Total Capital
46.82% 26.80% 29.43% 28.26% 54.03% 55.57% 58.07% 43.22% 31.89% 37.28%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 1.00% 0.00% 1.62% 1.39% 1.47% 1.13%
Long-Term Debt to Total Capital
46.82% 26.80% 29.43% 28.26% 53.03% 55.57% 56.45% 41.83% 30.42% 36.15%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.78% 1.13% 1.37% 1.68% 1.30% 1.35% 1.22% 1.35% 1.96% 1.81%
Common Equity to Total Capital
52.40% 72.07% 69.20% 70.06% 44.67% 43.09% 40.71% 55.42% 66.15% 60.91%
Debt to EBITDA
3.80 2.62 8.48 79.31 11.51 4.11 13.30 2.91 1.83 2.92
Net Debt to EBITDA
0.58 1.00 5.03 50.67 9.10 3.49 11.73 2.08 1.03 1.89
Long-Term Debt to EBITDA
3.80 2.62 8.48 79.31 11.30 4.11 12.93 2.82 1.74 2.83
Debt to NOPAT
5.55 4.90 -95.42 -8.11 -135.75 10.52 -29.23 8.84 7.28 17.32
Net Debt to NOPAT
0.85 1.86 -56.63 -5.18 -107.31 8.94 -25.77 6.30 4.09 11.19
Long-Term Debt to NOPAT
5.55 4.90 -95.42 -8.11 -133.22 10.52 -28.41 8.56 6.94 16.80
Altman Z-Score
2.82 2.85 2.06 2.01 2.30 2.26 1.55 2.60 3.28 2.20
Noncontrolling Interest Sharing Ratio
1.51% 1.73% 2.13% 2.54% 2.93% 2.98% 2.64% 2.61% 2.88% 2.69%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
3.44 1.95 1.66 1.50 1.69 1.49 1.37 1.67 1.77 1.59
Quick Ratio
2.65 1.13 0.97 0.92 1.05 0.93 0.85 1.13 1.17 0.97
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
138 69 -61 135 24 73 -423 -352 82 70
Operating Cash Flow to CapEx
779.32% 464.85% 124.07% 446.32% 237.00% 284.52% 183.07% 386.61% 266.04% 167.02%
Free Cash Flow to Firm to Interest Expense
8.98 8.27 -9.11 4.72 0.54 1.40 -7.26 -25.42 6.09 5.67
Operating Cash Flow to Interest Expense
15.49 14.97 3.64 5.41 2.49 3.30 1.89 13.82 8.57 5.97
Operating Cash Flow Less CapEx to Interest Expense
13.50 11.75 0.71 4.19 1.44 2.14 0.86 10.25 5.35 2.40
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.81 0.87 0.75 0.79 0.82 0.94 1.01 1.10 1.24 1.10
Accounts Receivable Turnover
7.46 7.44 6.20 5.93 5.16 5.50 5.69 5.39 5.90 5.56
Inventory Turnover
5.78 5.70 6.46 8.09 7.66 7.80 7.94 7.52 7.64 7.70
Fixed Asset Turnover
19.99 16.17 11.84 10.68 9.86 10.89 11.12 10.70 10.98 9.48
Accounts Payable Turnover
9.30 6.69 5.92 6.89 5.78 5.49 5.75 6.17 7.53 7.18
Days Sales Outstanding (DSO)
48.92 49.05 58.84 61.55 70.77 66.37 64.15 67.78 61.86 65.64
Days Inventory Outstanding (DIO)
63.18 64.06 56.54 45.12 47.66 46.78 45.96 48.55 47.77 47.41
Days Payable Outstanding (DPO)
39.25 54.60 61.67 52.97 63.16 66.54 63.44 59.16 48.45 50.84
Cash Conversion Cycle (CCC)
72.85 58.52 53.71 53.70 55.26 46.61 46.67 57.17 61.18 62.20
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
1,603 1,517 1,486 1,430 1,621 1,652 1,630 1,243 821 862
Invested Capital Turnover
1.56 1.45 1.23 1.30 1.33 1.52 1.65 1.96 2.39 2.13
Increase / (Decrease) in Invested Capital
86 30 56 -191 -31 22 388 421 -41 -48
Enterprise Value (EV)
5,108 3,641 2,606 3,416 4,679 4,198 2,782 3,097 2,594 1,628
Market Capitalization
4,896 3,435 2,288 3,102 3,874 3,322 1,864 2,641 2,405 1,371
Book Value per Share
$30.84 $28.82 $25.86 $24.65 $20.21 $19.63 $18.08 $20.31 $16.51 $15.96
Tangible Book Value per Share
$6.55 $4.66 $1.43 ($1.67) ($11.10) ($12.95) ($16.78) $3.50 $2.80 $0.92
Total Capital
2,654 1,819 1,688 1,593 1,828 1,802 1,751 1,419 955 993
Total Debt
1,242 487 497 450 988 1,001 1,017 613 305 370
Total Long-Term Debt
1,242 487 497 450 969 1,001 988 594 290 359
Net Debt
191 185 295 288 781 851 896 437 171 239
Capital Expenditures (CapEx)
31 27 20 35 46 61 60 49 44 44
Debt-free, Cash-free Net Working Capital (DFCFNWC)
236 210 129 86 192 176 152 185 200 161
Debt-free Net Working Capital (DFNWC)
1,288 512 331 249 399 326 272 362 333 292
Net Working Capital (NWC)
1,288 512 331 249 380 326 243 342 319 281
Net Nonoperating Expense (NNE)
-17 1.14 4.34 23 50 43 62 9.09 6.78 6.37
Net Nonoperating Obligations (NNO)
191 185 295 288 781 851 896 437 171 239
Total Depreciation and Amortization (D&A)
62 59 70 102 101 120 130 64 69 78
Debt-free, Cash-free Net Working Capital to Revenue
9.68% 9.67% 7.18% 4.34% 8.82% 7.03% 6.38% 9.19% 9.93% 8.57%
Debt-free Net Working Capital to Revenue
52.75% 23.56% 18.44% 12.54% 18.35% 13.02% 11.44% 17.92% 16.56% 15.52%
Net Working Capital to Revenue
52.75% 23.56% 18.44% 12.54% 17.50% 13.02% 10.25% 16.94% 15.87% 14.93%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$5.27 $2.13 ($0.22) ($1.83) ($1.44) $1.24 ($2.53) $1.48 $0.83 $0.33
Adjusted Weighted Average Basic Shares Outstanding
45.37M 45.42M 45.10M 44.30M 40.25M 39.56M 39.24M 38.66M 38.21M 38.22M
Adjusted Diluted Earnings per Share
$5.18 $2.11 ($0.22) ($1.83) ($1.44) $1.23 ($2.53) $1.45 $0.82 $0.33
Adjusted Weighted Average Diluted Shares Outstanding
46.19M 45.84M 45.10M 44.30M 40.25M 39.98M 39.24M 39.39M 38.64M 38.51M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
45.18M 45.58M 45.29M 45.01M 40.46M 39.96M 39.54M 38.78M 38.33M -27M
Normalized Net Operating Profit after Tax (NOPAT)
227 134 15 28 61 100 19 113 105 32
Normalized NOPAT Margin
9.28% 6.16% 0.82% 1.40% 2.78% 3.99% 0.81% 5.59% 5.22% 1.69%
Pre Tax Income Margin
11.66% 5.86% -0.88% -6.25% -2.61% 2.92% -4.59% 6.67% 4.20% 1.97%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
17.25 15.14 -1.73 -3.38 -0.36 2.36 -0.91 10.57 7.20 3.96
NOPAT to Interest Expense
14.55 11.91 -0.77 -1.94 -0.17 1.82 -0.60 5.01 3.09 1.74
EBIT Less CapEx to Interest Expense
15.27 11.92 -4.67 -4.59 -1.41 1.20 -1.94 6.99 3.97 0.38
NOPAT Less CapEx to Interest Expense
12.57 8.69 -3.71 -3.15 -1.22 0.66 -1.63 1.43 -0.13 -1.83
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
41.47% 0.00% -177.77% -10.25% 0.00% 47.70% 0.00% 0.00% 0.00% 255.17%

Quarterly Metrics And Ratios for Itron

This table displays calculated financial ratios and metrics derived from Itron's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.61% 6.18% 9.75% 12.57% 22.00% 23.46% 33.24% 25.28% 4.06% -3.74% -13.57%
EBITDA Growth
17.06% 28.32% 29.96% 58.66% 2,107.09% 120.96% 191.28% 381.55% -85.37% 132.42% -34.59%
EBIT Growth
20.39% 31.83% 34.35% 84.66% 633.06% 324.35% 853.74% 199.58% -293.61% 110.45% 142.42%
NOPAT Growth
21.38% 17.58% 78.13% 94.66% 785.47% 77.46% 537.88% 209.46% -666.19% 133.51% 118.67%
Net Income Growth
26.19% 30.42% 95.59% 106.59% 530.23% 104.59% 802.17% 168.09% -1,443.42% 137.57% 542.77%
EPS Growth
26.79% 29.90% 95.40% 107.55% 530.77% 97.96% 866.67% 164.63% -1,400.00% 136.03% 325.00%
Operating Cash Flow Growth
74.58% 66.72% 91.57% 24.44% 2,790.69% 467.57% 129.17% 175.87% -81.18% -195.48% -19.46%
Free Cash Flow Firm Growth
25.51% -331.63% -33.20% -4,155.14% -232.76% 146.43% -175.06% -91.43% -48.00% -126.70% -45.19%
Invested Capital Growth
5.82% 5.65% 9.19% 8.97% 6.12% 2.05% 6.38% 1.66% -2.46% 3.92% -4.10%
Revenue Q/Q Growth
-0.93% -0.42% 1.05% 0.93% 4.55% 2.92% 3.64% 9.39% 5.80% 11.08% -2.55%
EBITDA Q/Q Growth
11.99% -11.80% 15.79% 2.35% 22.76% -10.67% 41.37% 1,323.74% -87.71% 17.75% 236.64%
EBIT Q/Q Growth
20.40% -15.22% 16.21% 1.48% 31.84% -13.59% 59.74% 392.95% -204.95% 94.20% 116.68%
NOPAT Q/Q Growth
15.09% -25.69% 41.54% 0.28% 11.48% 12.58% 54.67% 453.12% -128.86% 304.67% 126.54%
Net Income Q/Q Growth
11.58% -25.78% 52.16% 0.14% 15.32% 11.31% 60.72% 308.55% -154.84% 390.83% 112.13%
EPS Q/Q Growth
12.70% -25.88% 54.55% -1.79% 15.46% 11.49% 64.15% 303.85% -153.06% 444.44% 110.98%
Operating Cash Flow Q/Q Growth
-9.68% 22.28% 26.27% 25.20% -13.75% 40.51% -17.98% 2,808.33% 110.97% -187.60% -1.27%
Free Cash Flow Firm Q/Q Growth
12.35% 49.86% 17.40% -105.19% -183.06% 128.83% -2,614.77% -93.28% 195.31% -146.61% 187.05%
Invested Capital Q/Q Growth
1.69% -1.51% 2.99% 2.58% 3.77% 1.79% 2.79% -0.10% -2.37% 6.11% -1.77%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
35.78% 34.90% 34.06% 34.55% 34.03% 34.03% 33.38% 32.15% 31.61% 30.12% 28.53%
EBITDA Margin
14.83% 13.11% 14.81% 12.92% 12.74% 10.85% 12.50% 9.17% 0.70% 6.06% 5.72%
Operating Margin
12.55% 10.24% 12.01% 10.61% 10.41% 8.54% 9.79% 6.49% -2.10% 2.65% 1.64%
EBIT Margin
12.54% 10.32% 12.12% 10.54% 10.48% 8.31% 9.90% 6.43% -2.40% 2.42% 1.38%
Profit (Net Income) Margin
10.76% 9.56% 12.82% 8.51% 8.58% 7.78% 7.19% 4.64% -2.43% 4.70% 1.06%
Tax Burden Percent
79.42% 83.85% 95.74% 77.36% 79.41% 90.79% 72.39% 73.19% 99.42% 203.60% 90.43%
Interest Burden Percent
108.03% 110.42% 110.47% 104.42% 103.09% 103.08% 100.35% 98.65% 102.01% 95.34% 84.92%
Effective Tax Rate
20.58% 16.15% 4.26% 22.64% 20.59% 9.21% 27.61% 26.81% 0.00% -103.60% 9.57%
Return on Invested Capital (ROIC)
15.38% 13.43% 17.75% 12.74% 12.61% 11.22% 10.12% 6.35% -1.82% 6.64% 1.88%
ROIC Less NNEP Spread (ROIC-NNEP)
18.88% 16.60% 21.06% 13.43% 13.54% 11.29% 10.35% 6.12% -3.52% 5.52% 1.23%
Return on Net Nonoperating Assets (RNNOA)
1.80% 2.28% 3.94% 2.91% 2.16% 2.15% 2.25% 1.33% -0.83% 1.38% 0.29%
Return on Equity (ROE)
17.17% 15.71% 21.68% 15.65% 14.77% 13.37% 12.37% 7.69% -2.64% 8.02% 2.17%
Cash Return on Invested Capital (CROIC)
9.13% 8.85% 5.06% 3.58% 4.76% 4.60% -0.78% 1.54% 1.32% -4.20% -2.04%
Operating Return on Assets (OROA)
9.92% 8.38% 9.92% 8.57% 9.34% 7.25% 8.47% 5.14% -1.79% 1.82% 1.06%
Return on Assets (ROA)
8.52% 7.76% 10.49% 6.92% 7.65% 6.79% 6.15% 3.71% -1.82% 3.53% 0.81%
Return on Common Equity (ROCE)
16.93% 15.47% 21.35% 15.37% 14.52% 13.14% 12.14% 7.53% -2.59% 7.85% 2.12%
Return on Equity Simple (ROE_SIMPLE)
17.11% 0.00% 16.87% 15.24% 11.88% 0.00% 6.09% 3.28% -1.92% 0.00% -8.22%
Net Operating Profit after Tax (NOPAT)
61 53 71 50 50 45 40 26 -7.28 25 6.23
NOPAT Margin
9.97% 8.58% 11.50% 8.21% 8.26% 7.75% 7.09% 4.75% -1.47% 5.39% 1.48%
Net Nonoperating Expense Percent (NNEP)
-3.50% -3.17% -3.31% -0.69% -0.93% -0.07% -0.24% 0.23% 1.71% 1.12% 0.65%
Return On Investment Capital (ROIC_SIMPLE)
2.20% 1.98% - - - 2.46% - - - 1.49% -
Cost of Revenue to Revenue
64.22% 65.10% 65.94% 65.45% 65.97% 65.97% 66.62% 67.85% 68.39% 69.88% 71.47%
SG&A Expenses to Revenue
14.31% 13.88% 12.94% 14.52% 14.25% 14.14% 13.66% 14.62% 15.27% 16.63% 15.08%
R&D to Revenue
8.25% 9.52% 8.33% 8.71% 8.68% 9.34% 9.21% 9.90% 10.02% 9.97% 10.41%
Operating Expenses to Revenue
23.22% 24.66% 22.04% 23.94% 23.63% 25.49% 23.59% 25.66% 33.72% 27.47% 26.89%
Earnings before Interest and Taxes (EBIT)
76 63 75 64 63 48 56 35 -12 11 5.82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
90 80 91 79 77 63 70 50 3.48 28 24
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.18 3.52 3.56 3.66 3.08 2.62 2.23 2.72 2.14 1.96 1.74
Price to Tangible Book Value (P/TBV)
12.23 16.58 21.19 35.76 17.30 16.19 18.17 31.80 37.73 35.31 152.91
Price to Revenue (P/Rev)
1.94 2.01 2.00 1.93 1.84 1.58 1.33 1.70 1.38 1.27 1.05
Price to Earnings (P/E)
18.72 20.48 21.31 24.20 26.23 35.44 36.84 84.64 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.34% 4.88% 4.69% 4.13% 3.81% 2.82% 2.71% 1.18% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.99 3.19 3.12 3.09 2.85 2.40 2.02 2.43 1.92 1.75 1.58
Enterprise Value to Revenue (EV/Rev)
1.99 2.09 2.11 2.08 1.92 1.68 1.46 1.83 1.54 1.45 1.22
Enterprise Value to EBITDA (EV/EBITDA)
14.33 15.62 16.43 16.92 16.91 19.59 19.84 33.36 72.91 44.47 0.00
Enterprise Value to EBIT (EV/EBIT)
17.52 19.25 20.32 21.12 21.75 28.80 33.50 87.92 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
20.80 22.82 23.54 26.48 27.39 36.61 38.47 76.85 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
18.12 21.45 24.64 27.88 26.60 29.14 46.94 78.51 152.23 106.38 43.14
Enterprise Value to Free Cash Flow (EV/FCFF)
33.67 37.00 64.37 90.04 61.61 52.74 0.00 159.39 143.87 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.82 0.88 0.91 0.98 0.33 0.37 0.39 0.37 0.38 0.42 0.45
Long-Term Debt to Equity
0.52 0.88 0.91 0.98 0.33 0.37 0.39 0.37 0.38 0.42 0.45
Financial Leverage
0.10 0.14 0.19 0.22 0.16 0.19 0.22 0.22 0.23 0.25 0.24
Leverage Ratio
2.14 2.19 2.24 2.32 1.99 1.97 2.03 2.03 2.04 2.04 2.05
Compound Leverage Factor
2.31 2.42 2.47 2.43 2.05 2.04 2.04 2.01 2.08 1.95 1.74
Debt to Total Capital
45.18% 46.82% 47.55% 49.58% 24.74% 26.80% 27.92% 26.96% 27.51% 29.43% 30.88%
Short-Term Debt to Total Capital
16.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
28.56% 46.82% 47.55% 49.58% 24.74% 26.80% 27.92% 26.96% 27.51% 29.43% 30.88%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.75% 0.78% 0.78% 0.85% 1.12% 1.13% 1.15% 1.41% 1.39% 1.37% 1.44%
Common Equity to Total Capital
54.06% 52.40% 51.67% 49.57% 74.14% 72.07% 70.93% 71.62% 71.11% 69.20% 67.68%
Debt to EBITDA
3.66 3.80 4.01 4.30 1.76 2.62 3.22 4.30 11.83 8.48 -8.73
Net Debt to EBITDA
0.35 0.58 0.84 1.11 0.60 1.00 1.53 2.09 6.71 5.03 -4.96
Long-Term Debt to EBITDA
2.31 3.80 4.01 4.30 1.76 2.62 3.22 4.30 11.83 8.48 -8.73
Debt to NOPAT
5.31 5.55 5.75 6.73 2.85 4.90 6.24 9.91 -26.26 -95.42 -5.60
Net Debt to NOPAT
0.51 0.85 1.20 1.73 0.97 1.86 2.98 4.82 -14.90 -56.63 -3.18
Long-Term Debt to NOPAT
3.35 5.55 5.75 6.73 2.85 4.90 6.24 9.91 -26.26 -95.42 -5.60
Altman Z-Score
2.46 2.62 2.57 2.41 2.92 2.75 2.43 2.27 1.80 2.09 1.90
Noncontrolling Interest Sharing Ratio
1.43% 1.51% 1.54% 1.80% 1.68% 1.73% 1.83% 1.98% 2.08% 2.13% 2.14%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.93 3.44 3.36 3.16 1.90 1.95 1.82 1.73 1.68 1.66 1.61
Quick Ratio
1.49 2.65 2.53 2.31 1.11 1.13 1.03 0.99 0.93 0.97 0.96
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-29 -33 -66 -80 -39 14 -50 1.97 29 -31 66
Operating Cash Flow to CapEx
1,554.58% 824.55% 985.97% 727.38% 578.14% 558.22% 587.10% 742.67% 20.70% -268.05% 352.21%
Free Cash Flow to Firm to Interest Expense
-5.20 -5.93 -11.80 -34.96 -20.61 7.65 -20.30 1.00 14.28 -17.19 39.39
Operating Cash Flow to Interest Expense
12.89 14.28 11.65 22.58 21.82 25.61 13.94 21.02 0.69 -7.27 8.86
Operating Cash Flow Less CapEx to Interest Expense
12.06 12.55 10.47 19.48 18.05 21.02 11.57 18.19 -2.66 -9.98 6.34
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.79 0.81 0.82 0.81 0.89 0.87 0.86 0.80 0.75 0.75 0.77
Accounts Receivable Turnover
7.12 7.46 7.32 7.40 7.07 7.44 7.06 6.65 5.96 6.20 6.17
Inventory Turnover
5.60 5.78 5.73 5.55 5.50 5.70 5.86 6.04 5.83 6.46 6.92
Fixed Asset Turnover
20.59 19.99 19.23 18.46 17.46 16.17 15.38 13.58 12.36 11.84 11.04
Accounts Payable Turnover
8.21 9.30 8.40 7.39 6.49 6.69 6.11 6.59 5.67 5.92 6.18
Days Sales Outstanding (DSO)
51.25 48.92 49.84 49.35 51.59 49.05 51.71 54.87 61.19 58.84 59.13
Days Inventory Outstanding (DIO)
65.18 63.18 63.71 65.75 66.34 64.06 62.28 60.46 62.63 56.54 52.76
Days Payable Outstanding (DPO)
44.44 39.25 43.43 49.39 56.26 54.60 59.74 55.36 64.34 61.67 59.09
Cash Conversion Cycle (CCC)
72.00 72.85 70.12 65.72 61.67 58.52 54.25 59.97 59.48 53.71 52.81
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,630 1,603 1,627 1,580 1,540 1,517 1,490 1,450 1,451 1,486 1,401
Invested Capital Turnover
1.54 1.56 1.54 1.55 1.53 1.45 1.43 1.34 1.24 1.23 1.27
Increase / (Decrease) in Invested Capital
90 86 137 130 89 30 89 24 -37 56 -60
Enterprise Value (EV)
4,874 5,108 5,081 4,879 4,384 3,641 3,006 3,520 2,792 2,606 2,208
Market Capitalization
4,733 4,896 4,802 4,539 4,209 3,435 2,754 3,275 2,512 2,288 1,901
Book Value per Share
$32.94 $30.84 $29.99 $27.02 $29.89 $28.82 $27.23 $26.53 $25.86 $25.86 $24.23
Tangible Book Value per Share
$8.57 $6.55 $5.04 $2.77 $5.33 $4.66 $3.33 $2.27 $1.47 $1.43 $0.28
Total Capital
2,753 2,654 2,610 2,500 1,841 1,819 1,745 1,683 1,647 1,688 1,616
Total Debt
1,244 1,242 1,241 1,240 455 487 487 454 453 497 499
Total Long-Term Debt
786 1,242 1,241 1,240 455 487 487 454 453 497 499
Net Debt
121 191 258 319 155 185 233 221 257 295 284
Capital Expenditures (CapEx)
4.64 9.68 6.62 7.11 7.15 8.58 5.81 5.60 6.90 4.86 4.22
Debt-free, Cash-free Net Working Capital (DFCFNWC)
254 236 251 234 218 210 199 177 169 129 91
Debt-free Net Working Capital (DFNWC)
1,377 1,288 1,233 1,154 519 512 454 410 366 331 307
Net Working Capital (NWC)
919 1,288 1,233 1,154 519 512 454 410 366 331 307
Net Nonoperating Expense (NNE)
-4.82 -5.97 -8.13 -1.85 -1.92 -0.17 -0.61 0.59 4.76 3.26 1.76
Net Nonoperating Obligations (NNO)
121 191 258 319 155 185 233 221 257 295 284
Total Depreciation and Amortization (D&A)
14 17 17 14 14 15 15 15 15 17 18
Debt-free, Cash-free Net Working Capital to Revenue
10.37% 9.68% 10.42% 9.94% 9.56% 9.67% 9.64% 9.21% 9.34% 7.18% 5.02%
Debt-free Net Working Capital to Revenue
56.32% 52.75% 51.27% 49.11% 22.73% 23.56% 21.99% 21.31% 20.14% 18.44% 16.90%
Net Working Capital to Revenue
37.60% 52.75% 51.27% 49.11% 22.73% 23.56% 21.99% 21.31% 20.14% 18.44% 16.90%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.44 $1.29 $1.73 $1.12 $1.13 $0.98 $0.88 $0.53 ($0.26) $0.49 $0.09
Adjusted Weighted Average Basic Shares Outstanding
45.34M 45.37M 44.98M 45.75M 45.65M 45.42M 45.46M 45.44M 45.28M 45.10M 45.14M
Adjusted Diluted Earnings per Share
$1.42 $1.26 $1.70 $1.10 $1.12 $0.97 $0.87 $0.53 ($0.26) $0.49 $0.09
Adjusted Weighted Average Diluted Shares Outstanding
46.17M 46.19M 45.84M 46.53M 46.36M 45.84M 45.95M 45.78M 45.28M 45.10M 45.33M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
45.59M 45.18M 45.09M 44.96M 45.87M 45.58M 45.49M 45.46M 45.42M 45.29M 45.18M
Normalized Net Operating Profit after Tax (NOPAT)
60 55 71 50 50 51 39 27 18 7.12 5.77
Normalized NOPAT Margin
9.91% 9.03% 11.50% 8.19% 8.29% 8.87% 7.01% 4.95% 3.71% 1.52% 1.37%
Pre Tax Income Margin
13.55% 11.40% 13.39% 11.01% 10.81% 8.57% 9.94% 6.34% -2.45% 2.31% 1.18%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
13.62 11.31 13.31 28.04 33.42 25.66 22.71 17.59 -5.77 6.31 3.47
NOPAT to Interest Expense
10.82 9.41 12.63 21.84 26.34 23.92 16.25 12.99 -3.54 14.06 3.71
EBIT Less CapEx to Interest Expense
12.79 9.58 12.13 24.93 29.65 21.07 20.34 14.76 -9.12 3.60 0.95
NOPAT Less CapEx to Interest Expense
9.99 7.68 11.45 18.73 22.57 19.33 13.88 10.16 -6.89 11.35 1.19
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 41.47% 43.96% 52.94% 0.00% 0.00% 0.00% 0.00% 0.00% -177.77% -27.80%

Frequently Asked Questions About Itron's Financials

When does Itron's financial year end?

According to the most recent income statement we have on file, Itron's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Itron's net income changed over the last 9 years?

Itron's net income appears to be on an upward trend, with a most recent value of $241.12 million in 2024, rising from $15.00 million in 2015. The previous period was $98.32 million in 2023. Check out Itron's forecast to explore projected trends and price targets.

What is Itron's operating income?
Itron's total operating income in 2024 was $264.11 million, based on the following breakdown:
  • Total Gross Profit: $839.32 million
  • Total Operating Expenses: $575.21 million
How has Itron revenue changed over the last 9 years?

Over the last 9 years, Itron's total revenue changed from $1.88 billion in 2015 to $2.44 billion in 2024, a change of 29.6%.

How much debt does Itron have?

Itron's total liabilities were at $2.00 billion at the end of 2024, a 56.8% increase from 2023, and a 88.7% increase since 2015.

How much cash does Itron have?

In the past 9 years, Itron's cash and equivalents has ranged from $120.22 million in 2018 to $1.05 billion in 2024, and is currently $1.05 billion as of their latest financial filing in 2024.

How has Itron's book value per share changed over the last 9 years?

Over the last 9 years, Itron's book value per share changed from 15.96 in 2015 to 30.84 in 2024, a change of 93.3%.



This page (NASDAQ:ITRI) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners